Predict4Health operates as a pioneer in AI-based medical device software, collaborating closely with INSERM teams to enhance the quality of life for transplant and chronic disease patients. The company offers two solutions: Predigraft, a web-based platform for kidney transplant patient monitoring, featuring a unique AI predictive technology (iBox) achieving over 80% accuracy in predicting long-term kidney graft survival and Apilife, a web-based telemonitoring platform with personalized support for transplanted and chronic disease patients. Additionally, Predict4Health provides the Trialbox Solution, leveraging iBox as the first digital biomarker for virtualizing and expediting clinical trials, potentially reducing the time to market for new immunosuppressive drugs by up to 7 years.